ABERGER, FRITZ,GRUBER, WOLFGANG,LEBAN, JOHANN,KOHLHOF, HELLA,VITT, DANIEL,BAUMGARTNER, ROLAND
申请号：
CA2854542
公开号：
CA2854542A1
申请日:
2014.06.17
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present invention relates to a DYRK1B inhibitor for use in the treatmentof cancer,wherein in said cancer and/or in cells of said cancer the hedgehog signalingpathway isactivated, and in particular the activation of the hedgehog signaling pathwayisindependent of signaling by the G protein-coupled receptor Smoothened.
